| Literature DB >> 34074664 |
Kristina Callis Duffin1, Hervé Bachelez2, Philip J Mease3, Cheryl Rosen4, Amit Garg5, Eric Zudak6, Ori Elkayam7, Joseph F Merola8, Jeffrey Chau9, Mitsumasa Kishimoto10, Victoria Furer7, Philip S Helliwell11.
Abstract
Pustular psoriasis (PsO) is an uncommon variant of PsO that may present in a generalized or localized fashion with or without musculoskeletal or systemic inflammatory involvement.Generalized pustular PsO (GPP) presents as a widespread acute or subacute pustular eruption that may be familial and is often associated with severe flares and systemic inflammation. The palmoplantar pustulosis variant is localized to palms and soles, whereas acrodermatitis continua of Hallopeau is localized to the nail apparatus. Patients with pustular PsO may have overlapping plaque PsO and may develop psoriatic arthritis (PsA). Pustulosis is also a feature of both synovitis, acne, pustulosis, hyperostosis, osteomyelitis (SAPHO) syndrome and chronic non-bacterial osteomyelitis. At the 2020 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) annual meeting, members were given an overview of the cutaneous features of pustular PsO, SAPHO, and recent insights into the genetics of GPP, leading to new targeted drug therapies and the development of validated endpoints.Entities:
Keywords: SAPHO; generalized pustular psoriasis; palmoplantar pustulosis
Year: 2021 PMID: 34074664 DOI: 10.3899/jrheum.201673
Source DB: PubMed Journal: J Rheumatol Suppl ISSN: 0380-0903